Professional Documents
Culture Documents
To best meet the health care needs of consumers, DHG Pharma always pioneers in applying the latest
and most modern technology in the production lines, in order to improve manufacturing quality and
productivity. In 2020, the profits before tax of the company reached 821 billion VND (an increase of 15%
compared to the implementation in 2019), which illustrated the enterprise completed 114% of the profit
plan before tax (A Lan, 2021). DHG has explained the reason why its profit increased in 2020 due to the
increase in the sales of manufactured goods as well as DHG was focus on selling the company's strategic
and key products. Besides, well implementing projects to increase productivity and production efficiency
helped to reduce costs; selling and administrative expenses to accommodate the Covid-19 translation
period. It is said that DHG is a pioneer in the application of scientific research into products. The
company has given a long-term orientation of cooperation with leading scientists in Vietnam to develop
products from biotechnology to improve its qualify, using natural resources with exclusive specific
formulas. Typical of those are Naturenz - Products manufactured based on the application of
biotechnology in extracting enzymes from vegetables, supporting the treatment of liver diseases.
Furthermore, DHG Pharma is strengthened by the contribution of technical activities and production
from strategic shareholder Taisho to help reduce costs, shorten the time to upgrade the factory
according to PIC / s - GMP, Japan - GMP standards to facilitate export and bidding.